Propensity-matched comparisons across 11 Kaiser Permanente Southern California service areas showed similar 30-day composite ...
The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...
This study examines how key players in managed care drive postacute home health referrals, identifying tensions, limited ...
A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results